ArticlePrecision radiation oncology2025
Experimental design and control methods for dose rate optimization in a synchrotron-based proton therapy beamline.
Article in Precision radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lighting up FLASH and beyond: TLD response across four orders of magnitude in proton dose rate.Medical physics · 2026Article
- Experimental design and control methods for dose rate optimization in a synchrotron-based proton therapy beamline.Precision radiation oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Background: Ultra-high dose rate radiotherapy (typically defined >40 Gy/s) has shown promise for enhanced normal tissue sparing while maintaining tumor control, termed the FLASH effect when this biological response is observed. However, precise dose rate control remains a technical challenge in proton therapy systems, particularly for research applications investigating dose rate effects. Purpose: To develop and validate a passive beam modulation technique using tungsten scatterers for controllable dose rate adjustment in a synchrotron-based proton therapy beamline without modifying accelerator parameters. Methods: We investigated dose rate modulation using tungsten foils of varying thicknesses (0.1-3.5 mm) positioned upstream in an 87.2 MeV experimental proton beamline. Monte Carlo simulations using Geant4 were performed to model the dose rate variation as a function of the tungsten scatter's thickness. Experimental validation was conducted using an Advanced Markus ionization chamber for dose rate measurements and EBT-XD radiochromic films for lateral dose profile analysis. Five tungsten thicknesses were tested with full-spill deliveries (∼1400 monitor units (MUs), and ∼100 milliseconds (ms) pulse width). Results: An inverse exponential relationship between dose rate and scatterer thickness was observed, with measured dose rates ranging from 288.9±0.7 Gy/s (0.1 mm tungsten) to 10.2±0.2 Gy/s (3.5 mm tungsten). Experimental measurements validated the accuracy of Monte Carlo predictions at the standard condition (1400 MU delivered in 100 ms) by falling within the 95% confidence intervals. Lateral beam profiles demonstrated progressive broadening with increased scatterer thickness, and the film measurements showed good agreements with Monte Carlo simulation (<2% difference at beam center). Conclusions: Tungsten scatterer thickness modulation provides a practical, controllable method for dose rate adjustment spanning conventional to FLASH regimes. This passive approach enables precise dose rate control for preclinical radiobiological research without requiring modifications of accelerator structure and parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.